Correction: Astragaloside IV alleviates tacrolimus-induced chronic nephrotoxicity via p62-Keap1-Nrf2 pathway

Ping Gao; Xiaoyi Du; Lili Liu; Hua Xu; Maochang Liu; Xinlei Guan; Chengliang Zhang

PMC · DOI:10.3389/fphar.2025.1710116·October 27, 2025

Correction: Astragaloside IV alleviates tacrolimus-induced chronic nephrotoxicity via p62-Keap1-Nrf2 pathway

Ping Gao, Xiaoyi Du, Lili Liu, Hua Xu, Maochang Liu, Xinlei Guan, Chengliang Zhang

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Genes3

KEAP1 NFE2L2 NUP62

Proteins3

Chemicals2

Astragaloside IV tacrolimus

Figures2

Click any figure to enlarge with its caption.

Keywords

astragaloside IVtacrolimuschronic nephrotoxicityp62-Keap1-Nrf2 pathwayoxidative stress

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsDrug-Induced Hepatotoxicity and Protection · Renal Transplantation Outcomes and Treatments · Nephrotoxicity and Medicinal Plants

Full text

In the published article there were mistakes in Figures 3D, 6E as published. In Figure 3D, the image of Tac group (the second group) was misused. In Figure 6E, the Western blot of p62 was misused. The corrected Figures 3, 6 appear below.

The original article has been updated.